Dr. Agarwal's Health Care Ltd.

Industry:

Hospital & Healthcare Services

Issue Details

  • Open Date

    29 Jan 2025
  • Close Date

    31 Jan 2025
  • Size (in Crs.)

    2151.75

  • Size (Shares)

    -
  • Listing On

    BSE, NSE

Issue Terms

  • Price Range

    -20
  • Lot Size

    35

  • Type

    Book building

  • Face Value

    1

  • Market Lot

    1

Objective of the Issue

Our Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:1. Repayment/prepayment, in part or full, of certain of our borrowings; and2. General corporate purposes and unidentified inorganic acquisition

Description

We provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations,diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceuticalproducts. We had a market share of approximately 25% of the total eye care service chain market in India during the FinancialYear 2024 (Source: CRISIL MI&A Report). With long-standing operational history, we endeavour to address all the needs ofour patients in their ey...  Show More

Address

1st Floor, Buhari Towers, No.4 , Moores Road, Off Greams Road , Near Asan Memorial School

Chennai

600006

State

Tamil Nadu

Phone No.

044-43787777

Website

www.dragarwals.co.in

Promoter Holding

Promoters:

Adil Agarwal, Adil Agarwal Family Trust, Agarwal’S Eye Institute, Agarwals Eye Institute Pvt Ltd, Amar Agarwal, Amar Agarwal Family Trust, Anosh Agarwal, Anosh Agarwal Family Trust, Ashar Agarwal, Ashar Agarwal Family Trust, Ashvin Agarwal, Ashvin Agarwal Family Trust, Athiya Agarwal

Total Share Capital

116359650

Offered to Public

75304970

% Promoter's Holding (Pre-Issue)  

37.73

% Promoter's Holding (Post-Issue)  

32.45

Shares on offer

Total Share Offer

116359650

Of above offred to public

75304970

Post Issue shares

NA

Post Issue Promoters

32.45

Lead Managers to the Issue:

Jefferies India Pvt Ltd., Kotak Mahindra Capital Co Ltd, Morgan Stanley India Co Pvt Ltd, Motilal Oswal Investment Advisors Pvt Ltd

Registrar Details

Registrar Name:

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Address

Karvy Selenium Tower B, Plot 31-32 , Gachibowli,Financial District , Nanakramguda , Hyderabad

500032

Phone No.

040 - 67162222/18003094001

Website

www.kfintech.com

Fax

-

Prudent Corporate Advisory Services Ltd.
"Prudent House", Panjrapole Cross Road,
Nr. Polytechnic, Ambawadi,
Ahmedabad - 380 015, Gujarat, India.
For Queries:
[email protected]
1800 419 5051 (Toll Free)
Compliance Officer:
Mrs. Rima Patel
[email protected]
(079) 40209600
Social Media

Prudent Corporate Advisory Services Ltd.(PCAS): Member of NSE & BSE – SEBI Registration No as stock broker: INZ000293634. Member ID : - NSE : 90209, BSE : 6733, CDSL – IN-DP- 477-2020 (DP ID: 12090600), Research Analyst - INH000018115, CIN - L91120GJ2003PLC042458.

Registered Address: Prudent House, Panjrapole Cross Road, Nr. Polytechnic, Ambawadi, Ahmedabad - 380015, Gujarat, India.

For any complaints pertaining to securities / broking please write a mail to [email protected]

Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI

Investor Alert:
  1. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  2. Prevent Unauthorized transactions in your Trading / Demat account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange / CDSL on your mobile/email at the end of the day / same day.......... Issued in the interest of investors.
  3. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor's account.
  4. Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  5. Filing complaints on SCORES – Easy & quick
    • a. Register on SCORES portal b. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. c. Benefits: i. Effective communication. ii.Speedy redressal of the grievances.
  6. SEBI COMPLAINTS REDRESS SYSTEM Link :- https://scores.gov.in/scores/Welcome.html
  • Attention Investor:
  • 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the NSE's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 & BSE’s notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors

Company does not offer any scheme for any assured returns. In case, any such scheme offered by any of employee or other Authorized Person of the company, the same should not be accepted and no investment in such scheme to be made. In case of any such scheme offered by any person, kindly contact compliance team of the company on (+91) (79) 40209600. In case any investment made in such scheme, company will not be responsible for any claims or grievances for any loss on account of relying on the said scheme. 

Advertisement Disclosure - Non-Broking Products/Services e.g. Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc "These are not Exchange traded product and the Member is just acting as distributor and all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.”